• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用血管内超声虚拟组织学评估冠状动脉斑块成分:与青年心脏移植受者的长期临床结局的相关性。

Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients.

机构信息

Department of Cardiovascular Sciences, European Hospital, Rome.

出版信息

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):70-7. doi: 10.1002/ccd.25054. Epub 2013 Jul 16.

DOI:10.1002/ccd.25054
PMID:23765788
Abstract

OBJECTIVES

To assess coronary plaque composition by virtual histology intravascular ultrasound (VH-IVUS) analysis in young adult recipients and to correlate these findings with time from heart transplant (HTx) and long-term outcomes.

BACKGROUND

Rapid progression of coronary allograft vasculopathy after heart transplantation is a powerful predictor of mortality and clinical events at long-term.

METHODS

Forty consecutive young adult recipients transplanted during childhood undergoing VH-IVUS during coronary surveillance have been prospectively included in this study. According to the time interval from HTx to VH-IVUS assessment, our cohort was divided into two groups (group A: ≤5 years, n = 13; group B: >5 years, n = 27).

RESULTS

Group B showed an higher percentage of necrotic core and dense calcium (12 ± 2 vs. 5 ± 1%, P = 0.04; 8.2 vs. 2.1%, P = 0.03; respectively). An "inflammatory plaque" (necrotic core and dense calcium ≥30%) was detected in 34.8% of patients in group B and in none among group A patients (P = 0.03). Patients in group B had a number of adverse clinical events significantly higher than group A patients (53.8 vs. 14.3%; HR 4.45; 95% CI 1.62-12.16; P = 0.029) at long-term follow-up (4.2 years). The multivariate regression analysis showed that age (HR 1.5; 95% CI 1.1-2.0; P = 0.007), time from HTx (HR 1.8; 95% CI 1.6-4.8; P = 0.02), and inflammatory plaque (HR 2.4; 95% CI 1.1-5.3; P = 0.03) were independent predictors of adverse clinical events.

CONCLUSIONS

This study supports the hypothesis that time-dependent differences in plaque composition, as assessed by VH-IVUS, occur after HTx in young adult recipients, probably determining an increased risk of long-term clinical events.

摘要

目的

通过虚拟组织学血管内超声(VH-IVUS)分析评估年轻成年心脏移植受者的冠状动脉斑块成分,并将这些发现与心脏移植(HTx)后时间和长期结果相关联。

背景

心脏移植后冠状动脉移植物血管病的快速进展是死亡率和长期临床事件的有力预测因素。

方法

本研究前瞻性纳入了 40 名在儿童时期接受心脏移植并在冠状动脉监测期间接受 VH-IVUS 检查的连续年轻成年受者。根据 HTx 至 VH-IVUS 评估的时间间隔,我们的队列分为两组(A 组:≤5 年,n=13;B 组:>5 年,n=27)。

结果

B 组的坏死核心和致密钙百分比更高(12±2%比 5±1%,P=0.04;8.2%比 2.1%,P=0.03)。B 组 34.8%的患者存在“炎症斑块”(坏死核心和致密钙≥30%),而 A 组无一例患者存在(P=0.03)。B 组患者的不良临床事件发生率明显高于 A 组(53.8%比 14.3%;HR 4.45;95%CI 1.62-12.16;P=0.029),长期随访(4.2 年)。多变量回归分析显示,年龄(HR 1.5;95%CI 1.1-2.0;P=0.007)、HTx 后时间(HR 1.8;95%CI 1.6-4.8;P=0.02)和炎症斑块(HR 2.4;95%CI 1.1-5.3;P=0.03)是不良临床事件的独立预测因素。

结论

这项研究支持这样一种假设,即 VH-IVUS 评估的斑块成分在年轻成年心脏移植受者中存在时间依赖性差异,可能导致长期临床事件风险增加。

相似文献

1
Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients.应用血管内超声虚拟组织学评估冠状动脉斑块成分:与青年心脏移植受者的长期临床结局的相关性。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):70-7. doi: 10.1002/ccd.25054. Epub 2013 Jul 16.
2
Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.心脏移植冠状动脉粥样硬化斑块的炎症负荷与早期复发性细胞排斥反应相关,并预示着血管病变进展的更高风险。
J Am Coll Cardiol. 2009 Apr 14;53(15):1279-86. doi: 10.1016/j.jacc.2008.12.041.
3
Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.非纤维粥样硬化病变表型与长期临床结局:来自 PROSPECT 研究的一项亚组研究分析。
JACC Cardiovasc Imaging. 2013 Aug;6(8):908-16. doi: 10.1016/j.jcmg.2013.04.008. Epub 2013 Jul 10.
4
Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.光学相干断层扫描用于儿童心脏移植后晚期幸存者心脏移植物血管病的特征描述。
J Heart Lung Transplant. 2016 Jan;35(1):74-79. doi: 10.1016/j.healun.2015.08.011. Epub 2015 Sep 3.
5
Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis.初发心脏移植受者早期动脉粥样硬化的评估:基于血管内超声衍生射频分析的研究
J Heart Lung Transplant. 2008 Jan;27(1):26-30. doi: 10.1016/j.healun.2007.10.005.
6
Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation.心脏移植术后1至20年心脏移植血管病的虚拟组织学血管内超声评估
J Heart Lung Transplant. 2009 Feb;28(2):156-62. doi: 10.1016/j.healun.2008.11.915.
7
Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound.经血管内超声检查,心脏移植患者接受抗胸腺细胞球蛋白诱导治疗与冠状动脉斑块进展减少相关。
Circ Heart Fail. 2016 Jan;9(1):e002252. doi: 10.1161/CIRCHEARTFAILURE.115.002252.
8
Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.血浆中分子脂质种类与冠状动脉斑块特征及心血管结局的关系:动脉粥样硬化斑块逆转-IVUS研究结果
Atherosclerosis. 2015 Dec;243(2):560-6. doi: 10.1016/j.atherosclerosis.2015.10.022. Epub 2015 Oct 23.
9
Discrepancy of calcium detection between gray scale intravascular ultrasound and spectral analysis of radiofrequency data.灰阶血管内超声与射频数据频谱分析的钙检测差异。
Int J Cardiol. 2013 Sep 10;167(6):2611-6. doi: 10.1016/j.ijcard.2012.06.123. Epub 2012 Jul 20.
10
Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients.通过血管内超声衍生的射频分析评估和表征心脏移植受者斑块成分的时间相关差异。
J Heart Lung Transplant. 2008 Mar;27(3):302-9. doi: 10.1016/j.healun.2007.12.003.

引用本文的文献

1
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART).依维莫司洗脱生物可吸收血管支架治疗心脏移植血管病(CART)的安全性和有效性。
Clin Res Cardiol. 2024 Jul;113(7):1017-1029. doi: 10.1007/s00392-023-02351-9. Epub 2024 Jan 3.
2
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.依维莫司洗脱生物可吸收血管支架系统治疗心脏移植血管病变:CART(心脏移植修复治疗)前瞻性多中心试点研究。
J Cardiovasc Transl Res. 2016 Feb;9(1):40-8. doi: 10.1007/s12265-015-9665-x. Epub 2015 Dec 18.
3
Evolving concepts and treatment strategies for cardiac allograft vasculopathy.
心脏移植血管病变的不断演变的概念和治疗策略。
Curr Treat Options Cardiovasc Med. 2014 Jan;16(1):278. doi: 10.1007/s11936-013-0278-x.